📑100 amp Vitaminas asoc 100 fcos de 50 o 100 ml Lidocaina viscosa 2g/100 ml 10 Lidocaina 4% uso topico-PAGO SIIF
Procurement process summary
This process is to purchase 100 amp Vitaminas asoc 100 fcos de 50 o 100 ml Lidocaina viscosa 2g/100 ml 10 Lidocaina 4% uso topico-PAGO SIIF.
This contract was awarded by 🇺🇾 NO VIGENTE Hospital Pasteur for an amount of UYU 4,800 to 1 supplier. It was published on 2007-11-08 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇺🇾 NO VIGENTE Hospital Pasteur Buying unitnot reported Publication date2007-11-08 Contest statusnot reported DescriptionCompra Directa 670/2007Awards
This award was granted to GRAYDON S.A. by NO VIGENTE Hospital Pasteur for an amount of UYU 4,800. The procurement process was conducted through open for the category of Not available. The award was granted on 2007-11-08.
| Supplier | Amount | Award date |
|---|---|---|
| 🇺🇾 GRAYDON S.A. | UYU 4,800 | 2007-11-08 |
Market context and opportunities
The execution of this contract allows the entity NO VIGENTE Hospital Pasteur to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberUY_ocds-yfs5dr-139823-R-213632080013Publication date2007-11-08Contract datenot reportedAward date2007-11-08Categoriesnot reportedPurchase modalityopenMethod detailsCompra DirectaStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
